News: Year - 2015

Press Releases
Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

WINNIPEG, Manitoba –(Marketwired – December 31, 2015) – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation”) announced that on December 30, 2015, it issued 251,392 common shares of the Corporation (“Common Shares”) in payment of $12,569.62 in interest owing on the Corporation’s…

> Read More

Press Releases
Kane Biotech Announces Amendments to Terms of Convertible Note and Warrants

WINNIPEG, Manitoba –(Marketwired – December 14, 2015) – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) today announced that the Corporation has entered into an agreement to: (a) extend the maturity date of its previously issued $500,000 principal amount…

> Read More

Press Releases
Kane Biotech receives $300,000 from Warrant Exercise

WINNIPEG, Manitoba –(Marketwired – November 10, 2015) – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation”) announced that on November 5, 2015 it received $300,000 from the exercising of 5,000,000 warrants at $.06 per share. The warrants were issued on December 9,…

> Read More

Press Releases
Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

WINNIPEG, Manitoba –(Marketwired – September 23, 2015) – Kane Biotech Inc. (TSX-V:KNE), (“Kane Biotech” or the “Corporation”), announced that on September 22, 2015, it issued 254,178 common shares of the Corporation (“Common Shares”) in payment of $12,708.91 in interest owing…

> Read More

Press Releases
Kane Biotech Announces Financing Update

WINNIPEG, Manitoba –(Marketwired – August 21, 2015) – Kane Biotech Inc. (TSX-V:KNE), (“Kane Biotech” or the “Company”), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms, wishes to announce that it is…

> Read More

Press Releases
Kane Biotech and the U.S. Army Institute of Surgical Research Sign Cooperative Research and Development Agreement Extension

WINNIPEG, Manitoba –(Marketwired – August 4, 2015) – Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms, is pleased to announce a three year Cooperative Research and Development…

> Read More

Press Releases
Kane Biotech Announces Financing and Business Update

WINNIPEG, Manitoba –(Marketwired – July 28, 2015) – Kane Biotech Inc. (TSX-V:KNE), (“Kane Biotech” or the “Company”), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms, wishes to announce the following financing…

> Read More